A phase II trial of paclitaxel in previously untreated patients with extensive-stage small cell lung cancer (SCLC)

Lung Cancer ◽  
1994 ◽  
Vol 11 ◽  
pp. 234
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Extensive Stage

scholarly journals Phase II Trial with Carboplatin and Bendamustine in Patients with Extensive Stage Small-Cell Lung Cancer

2007 ◽  
Vol 2 (4) ◽  
pp. 312-316 ◽  
Author(s):  
Wolf Köster ◽  
Andrea Heider ◽  
Norbert Niederle ◽  
Hansjochen Wilke ◽  
Georgios Stamatis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Extensive Stage

scholarly journals A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621

Lung Cancer ◽  
2014 ◽  
Vol 85 (2) ◽  
pp. 245-250 ◽  
Author(s):  
Julian R. Molina ◽  
Nathan R. Foster ◽  
Thanyanan Reungwetwattana ◽  
Garth D. Nelson ◽  
Andrew V. Grainger ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Phase Ii Trial ◽  
Src Kinase ◽  
Small Cell ◽  
Small Cell Lung ◽  
Extensive Stage

scholarly journals Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer

2009 ◽  
Vol 4 (12) ◽  
pp. 1555-1560 ◽  
Author(s):  
David R. Spigel ◽  
F Anthony Greco ◽  
John D. Zubkus ◽  
Patrick B. Murphy ◽  
Ruben A. Saez ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Extensive Stage

Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)

2006 ◽  
Vol 1 (9) ◽  
pp. 996-1001 ◽  
Author(s):  
Primo N. Lara ◽  
Kari Chansky ◽  
Angela M. Davies ◽  
Wilbur A. Franklin ◽  
Paul H. Gumerlock ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung ◽  
Southwest Oncology Group ◽  
Extensive Stage

scholarly journals Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)

2006 ◽  
Vol 1 (9) ◽  
pp. 996-1001 ◽  
Author(s):  
Primo N. Lara ◽  
Kari Chansky ◽  
Angela M. Davies ◽  
Wilbur A. Franklin ◽  
Paul H. Gumerlock ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung ◽  
Southwest Oncology Group ◽  
Extensive Stage

scholarly journals Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients with Extensive-Stage Small Cell Lung Cancer

2011 ◽  
Vol 6 (6) ◽  
pp. 1117-1120 ◽  
Author(s):  
Bryan J. Schneider ◽  
Shirish M. Gadgeel ◽  
Nithya Ramnath ◽  
Antoinette J. Wozniak ◽  
Grace K. Dy ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Maintenance Therapy ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Platinum Based Chemotherapy ◽  
Extensive Stage
Sign in / Sign up

Export Citation Format

Share Document